Roche

Shaking Hands
By  Mallory Hackett 11:26 am May 6, 2021
Pharma giant Eli Lilly has inked a series of deals with four diabetes management companies to integrate with its forthcoming Tempo Pen and Tempo Smart Button products. The companies that signed strategic international agreements with Eli Lilly are Dexcom, Glooko, myDiabby Healthcare and Roche. Through the agreements, Eli Lilly’s Tempo Pen and connected Tempo Smart Button will integrate with the...
MySugr and Novo Nordisk
By  Laura Lovett 02:53 pm April 7, 2021
Roche's diabetes management app mySugr's Logbook is now integrating with Novo Nordisk's connected insulin pens: the NovoPen 6 and NovoPen Echo Plus. Patients will be able connect the mySugr Logbook to their smart-pen device in order to create more data set and reports with more insights. According to the companies, the goal is to be able to share more insights with healthcare providers in order...
By  Laura Lovett 12:39 pm March 1, 2021
Swiss pharma company Roche’s insulin pump will be the next to support automated insulin delivery thanks to a partnership with French AI company Diabeloop. As part of the deal, users will be able to integrate Roche’s Accu-Chek Insights insulin pump with the Diabeloop monitoring system. This integration would result in a hybrid closed-loop system – a system designed to take the pressure off the...
By  Laura Lovett 02:41 pm December 29, 2020
The life science world has continued to deepen its interest in the digital space. While the mainstream life science news of the year was research on the coronavirus vaccine, when it came to digital the industries efforts were more varied. We saw new partnerships between pharma and digital health around topics such as respiration health, cardiovascular conditions and real-world data.  This year we...
By  Laura Lovett 01:56 pm September 21, 2020
Pharma giant Roche is adding a new remote-patient-monitoring tool to its Diabetes Care Platform. The new tool is specifically targeted towards patients who require more doctor-patient interactions. Through it, doctors and care team members can enroll their patients in the remote-monitoring program and then personalize the tool for each patient. Specifically, clinicians can control the length of...
By  Dave Muoio 02:58 pm August 13, 2020
Driving digital diagnosis. Roche and Israeli life sciences investment firm aMoon announced plans this week to launch an early-stage investment program called StarFinder Lab. Focused on novel diagnostic technologies, in particular, with the help of AI data analysis and digital health tools, the program will provide funding, mentoring and other strategic support such as a physical office space...
By  Laura Lovett 02:57 pm July 16, 2020
Pharma giant Roche and its subsidiary Genentech have inked a deal with PicnicHealth, a startup that helps patients access and share their medical records.  The real-world evidence deal will allow the pharmaceutical companies to have access to PicnicHealth’s set of de-identified patient records in order to gain insights about certain diseases and treatments. Patients must first consent to their...
By  Dave Muoio 02:57 pm January 2, 2020
On Apple and patents. A New York University School of Medicine cardiologist is unhappy with Apple Watch’s heart rate irregularity detection feature, which he claims in a new lawsuit infringes his own patent for atrial fibrillation detection technology. Filed in the US District Court for the Eastern District of New York on December 27, 2019, the suit describes Dr. Joseph Wiesel’s invention and his...
By  Dave Muoio 03:10 pm October 1, 2019
Sixth time's the charm? Roche’s Accu-Chek Connect Diabetes Management App has notched its sixth device recall from the FDA, this time due to meter-to-app data transfer issues for users with Android OS 8.0 and above. According to the agency’s posting, Roche notified partners, users and call centers of the issue and released and update addressing the problem before the end of that month. Prior to...
By  Dean Koh 11:28 pm June 12, 2019
At the 79th Annual Scientific Sessions of the American Diabetes Association in San Francisco, pharma giant Roche and India-based digital therapeutics company Wellthy Therapeutics presented real world data of improved diabetes care outcomes in a South Asian population when patients followed prescribed plan of medication and lifestyle modification in conjunction with a combination therapy of self-...